Mechanisms of airway inflammation in cystic fibrosis

Pediatric Allergy and Immunology, Supplement

Volumn 7, Issue 9, 1996, Pages 63-66

  Doring G ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Airway inflammation; Children; Cystic fibrosis; Cytokines; Lung infection; Phagocytosis

Indexed keywords

AIRWAY; BACTERIAL COLONIZATION; CONFERENCE PAPER; CYSTIC FIBROSIS; INFLAMMATION; PRIORITY JOURNAL;

EID: 0030498716     PISSN: 09065784     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1996.tb00398.x     Document Type: Conference Paper

References (31)

1. TIZZANO EF, BUCHWALD M. Cystic fibrosis: beyond the gene to therapy. J Pediatr 1992: 120: 337-19.
2. BEDROSSIAN CWM, GREENBERG SD, SINGER DB, et al. The lung in cystic fibrosis. A quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol 1976: 7: 195-204.
3. KHAN TZ, WAGENER JS, BOST T, et al. Early pulmonary inflammation in infants with cystic fibrosis. Am J Crit Care Med 1995: 151: 1075-82.
4. DORING G, DAUNER H-M. Clearance of Pseudomonas aeruginosa in different rat lung infection models. Am Rev Respir Dis 1988: 138: 1249-53.
5. DAL NOGARE AR, TOEWS GB, PIERCE AK. Increased salivary elastase precedes gram-negative bacillary colonization in postoperative patients. Am Rev Respir Dis 1987: 135: 671-75.
6. BERGER M. Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy. Rev Infect Dis 1990: 12: S401-S409.
7. SORDELLI DO, DJAFARI M, GARCIA VE, et al. Age-dependent pulmonary clearance of Pseudomonas aeruginosa in a mouse model: diminished migration of polymorphonuclear leukocytes to N-formyl-methionly-leucyl-phenylalanine. Infect immun 1992: 60: 1724-7.
8. DORING G, KNIGHT R, BELLON G. Immunology of cystic fibrosis. In: HODSON ME, GEDDES D, ed. Cystic fibrosis, Chapman & Hall, 1994.
9. LAM J, CHAN R, LAM K, et al. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis. Infect Immun 1980: 28: 546-56.
10. BALTIMORE RS, CHRISTIE CDC, SMITH GJW. Immunohistopathologic location of Pseudomonas aeruginosa in lungs of patients with cystic fibrosis. Am Rev Respir Dis 1989: 140: 1650-61.
11. KONSTAN MW, WALNEGA RW, HILLIARD KA, et al. Leukotriene B4 markedly elevated in the epithelial lining fluid of patients with cystc fibrosis. Am Rev Respir Dis 1993: 148: 896-901.
12. RICHMAN-EISENSTAT JB, JORENS PG, HEBERT CA, et al. Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases. Am J Physiol 1993: 264: 413-8.
13. MASSION PP, INOUE H, RICHMAN-EISENSTAT JBY, et al. Pseudomonas aeruginosa is chemotactic for neutrophils by stimulating interleukin-8 (IL-8) synthesis and secretion in human airway epithelial cells. Clin Res 1993: 41 :A138.
14. SAVILL JS, WYLLJE AH, HENSON JE, et al. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989: 83: 865-75.
15. GOLDSTEIN W, DURING G. Lysosomal enzymes and proteinase inhibitors in the sputum of patients with cystic fibrosis. Am Rev Respir Dis 1986: 134: 49-56.
16. DURING G. The role of neutrophil elastase in chronic inflammation. Am J Respir Crit Care Med 1994: 150: Sl14-S117.
17. BERGER M, SORENSEN RU, TOSI MF, et al. Complement receptor expression on neutrophils at an inflammatory site, the Pseudomonas-infected lung in cystic fibrosis. J Clin Invest 1989: 84: 1302-13.
18. TOSI MF, ZAKEM H, BERGER M. Neutrophil elastase cleaves C3bi on opsonized Pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest 1990: 86: 300-8.
19. DoRING G, GOLDSTEIN W, BOTZENHART K, et al. Elastase from polymorphonuclear leukocytes-a regulatory enzyme in immune complex disease. Clin Exp Immunol 1986: 64: 597-605.
20. DORING G, FRANK F, BOUDER C, HERBERT S, FLEISCHER B, BELLON G. Cleavage of Iymphocyte surface antigens CD2, CD4 and CDS by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J Immunol 1995: 154: 4842-50.
21. MEYER KC, ZIMMERMAN J. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis. J Lab Clin Med 1993: 121: 654-61.
22. REGELMANN WE, SIEFFERMAN CM, HERRON JM, et al. Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis. Pediatr Pulmonol 1995: 19: 1-9.
23. KOLLER DY, GOTZ M, EICHLER I, et al. Eosinophilic activation in cystic fibrosis. Thorax 1994: 49: 496-9.
24. MATHESON NR, WONG PS, TRAVIS J. Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidase. Biochem Biophys Res Commun 1979: 88: 402-9.
25. WILLMOTT RW, KASSAB JT, KILJAN PL, BENJAMIN WR, DOUGLAS SD, WOOD RE. Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am Rev Respir Dis 1990: 142: 365-8.
26. BONFIELD TL, PANUSKA JR, KONSTAN MW, et al. Inflammatory cvtokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995: 152: 2111-8.
27. BONFIELD TL, KONSTAN MW, BURFEIND P, et al. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol 1995: 13: 257-61.
28. ROSENSTEIN BJ, EIGEN H. Risks of alternate-day prednisone in patients with cystic fibrosis. Pediatrics 1990: 87: 245-6.
29. KONSTAN MW, BYARD PJ, HOPPEL CL, et al. Effect of high-dose ibuprofen in patients with cystic fibrosis. N Engl J Med 1995: 332: 848-54.
30. MCELVANEY NG, HUBBARD RC, BIRRER P, et al. Aerosol α-antirypsin treatment for cystic fibrosis. Lancet 1991. 337: 392-4.
31. VOGELMEIER C, HUBBARD RC, FELLS GA, et al. Anti-neutrophil elalstase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J Clin Invest 1991: 87: 482-8.